Results of a phase I/II clinical trial with OncoVEXGM-CSF, a second generation oncolytic herpes simplex virus.

被引：0
|
作者：
Coffin, RS
Hu, JC
Davis, CJ
James, ND
Love, C
Michael, A
Pandha, H
Steiner, J
Steven, NM
Coombes, C
机构：
[1] BioVex Ltd, Abingdon, Oxon, England
[2] Imperial Coll Sch Med, London, England
[3] Univ Birmingham, Birmingham, W Midlands, England
[4] St George Hosp, Sch Med, London, England
[5] Oxford Therapeut Consulting, Oxford, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：216S / 216S
页数：1
相关论文
共 50 条
  • [41] Intravitreal Sirolimus for the Treatment of Geographic Atrophy: Results of a Phase I/II Clinical Trial
    Petrou, Philip A.
    Cunningham, Denise
    Shimel, Katherine
    Harrington, Molly
    Hammel, Keri
    Cukras, Catherine A.
    Ferris, Frederick L.
    Chew, Emily Y.
    Wong, Wai T.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (01) : 330 - 338
  • [42] Daclizumab phase I/II trial in relapsing and remitting MS: MRI and clinical results
    Rose, J
    Burns, J
    Bjorklund, J
    Klein, J
    Watt, H
    Carlson, N
    MULTIPLE SCLEROSIS, 2005, 11 : S155 - S156
  • [43] Results of the first phase I/II clinical vaccination trial with direct injection of mRNA
    Weide, Benjamin
    Carralot, Jean-Philippe
    Reese, Anne
    Scheel, Birgit
    Eigentler, Thomas Kurt
    Hoerr, Ingmar
    Rammensee, Hans-Georg
    Garbe, Claus
    Pascolo, Steve
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (02) : 180 - 188
  • [44] Final results of phase I trial of HF10, oncolytic virus immunotherapy, in Japanese patients with refractory superficial cancers
    Yamazaki, N.
    Takahashi, A.
    Tsutsumida, A.
    Tanaka, M.
    Namikawa, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [45] Adenovirus/herpes simplex-thymidine kinase/ganciclovir complex: preliminary results of a phase I trial in patients with recurrent malignant gliomas
    Germano, IM
    Fable, J
    Gultekin, SH
    Silvers, A
    JOURNAL OF NEURO-ONCOLOGY, 2003, 65 (03) : 279 - 289
  • [46] Safety results of a phase I/II study with oncolytic herpes simplex virus, Nv1020, administered repeatedly via hepatic artery infusion prior to 2nd-line chemotherapy, in patients with colorectal adenocarcinoma metastatic to the liver
    Nemunaitis, John J.
    Geller, David A.
    Karrasch, Matthias
    Knoll, Anette E.
    Mescheder, Axel
    Senzer, Neil
    Tanabe, Kenneth K.
    Reid, Tony
    GASTROENTEROLOGY, 2008, 134 (04) : A824 - A824
  • [47] Adenovirus/Herpes Simplex-Thymidine Kinase/Ganciclovir Complex: Preliminary Results of a Phase I trial in Patients with Recurrent Malignant Gliomas
    Isabelle M. Germano
    Jennifer Fable
    S. Humayun Gultekin
    Adam Silvers
    Journal of Neuro-Oncology, 2003, 65 : 279 - 289
  • [48] Intravenous OV001 (NDV-HUJ) oncolytic virus in glioblastoma multiforme (GBM): A phase I/II trial
    Freeman, A
    Gomori, JM
    Linetsky, E
    Zakay-Rones, Z
    Panet, A
    Libson, E
    Irving, CS
    Galan, E
    Siegal, T
    NEURO-ONCOLOGY, 2004, 6 (04) : 375 - 375
  • [49] Phase I/II Trial of Urokinase Plasminogen Activator-Targeted Oncolytic Newcastle Disease Virus for Canine Intracranial Tumors
    Rossmeisl, John H.
    King, Jamie N.
    Robertson, John L.
    Weger-Lucarelli, James
    Elankumaran, Subbiah
    CANCERS, 2024, 16 (03)
  • [50] Treatment of mucocutaneous herpes simplex virus infections unresponsive to acyclovir with topical foscarnet cream in AIDS patients: A phase I/II study
    Javaly, K
    Wohlfeiler, M
    Kalayjian, R
    Klein, T
    Bryson, Y
    Grafford, K
    Martin-Munley, S
    Hardy, WD
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (04): : 301 - 306
12345